Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-25-004069
Filing Date
2025-01-29
Accepted
2025-01-29 06:17:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7839
  Complete submission text file 0001493152-25-004069.txt   9267
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Subject) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93202 | Film No.: 25566541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)